Company Filing History:
Years Active: 2013
Title: Innovations of Jing Tang in Pharmaceutical Chemistry
Introduction
Jing Tang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic potential.
Latest Patents
One of his key patents is titled "Pyrimidinyl-propionic acid derivatives and their use as PPAR agonists." This invention discloses compounds of Structural Formula (I), including their enantiomers, racemic bodies, pharmaceutically acceptable salts, solvates, or hydrates. The compounds are designed to activate PPAR-RXR heterodimers, which interact with specific DNA response elements within the promoter regions of target genes. This innovation is particularly relevant for the treatment and prevention of polycystic kidney disease and cancer.
Career Highlights
Jing Tang is affiliated with the Shanghai Institute of Materia Medica, where he conducts research and development in medicinal chemistry. His work has led to advancements in understanding how specific compounds can influence biological pathways.
Collaborations
Some of his notable coworkers include Jianhua Shen and Changlin Mei, who contribute to the collaborative efforts in research and development within the institute.
Conclusion
Jing Tang's innovative work in the field of pharmaceutical chemistry exemplifies the impact of research on developing new therapeutic agents. His contributions continue to advance the understanding of PPAR agonists and their potential applications in medicine.